The Institute for Comparative Cancer Investigation (ICCI) at the University of Guelph facilitates translational oncology research in companion animals at the OVC Mona Campbell Centre for Animal Cancer by managing clinical trials and the Companion Animal Tumour Sample Bank (CATSB). Our goals: to advance the understanding of cancer and improve treatment options to benefit both companion animal and human cancer patients.
Launched in 2007, the institute is the first of its kind in Canada, combining the expertise of researchers in basic cancer biology and clinicians in veterinary medicine to take an integrated approach to cancer studies that cannot easily be matched in human research settings. The ICCI is dedicated to furthering the understanding of the cancer for the benefit of all species, including humans.
ICCI entails collaborative research from 37 cancer investigators from ~8 departments across UoGuelph including cancer biologists, veterinarians, chemists, mathematicians, computer scientists, toxicologists, psychologists and and others who represent Guelph’s unique capacity to broaden the scope of research and deepen our understanding of cancer. Furthermore, ICCI includes external research groups from The Univeristy of Waterloo & The Univeristy of Toronto.
A key component of this groundbreaking initiative is the establishment of a world-class Animal Cancer Centre in the OVC Health Sciences Centre. The centre is dedicated to cancer diagnosis, treatment, teaching and clinical research.
Mona Campbell Centre for Animal Cancer and ICCI in the media:
ICCI Co-Assistant Director Geoff Wood recently had a "one health" study published in Nature Communications comparing cancer genomes from human mucosal melanoma, canine oral melanoma and equine melanoma. This study was the first study to sequence equine tumours, and first to compare the genomes of the above three species (University of Guelph story here).
CTV W5 featured a story about Max, an OVC patient and participant in an ICCI-coordinated, NIH funded multi-centre trial for dogs with osteosarcoma. This story highlighted two human patients who benefited from research done in canines.
Nationalpost published an article on the important contribution that companion animal cancer patients provide by participating in clinical research studies to veterinary and human healthcare.
CityNews Toronto visited the Mona Campbell Centre for Animal Cancer.
GuelphToday - series of photographs following a visit of one of ICCI's osteosarcoma patients to the Mona Campbell Centre for Animal Cancer.
Mona Campbell Centre for Animal Cancer received a national award in 2017 for comprehensive cancer care benefiting both humans and animals.
ICCI member Dr. Alicia Viloria-Petit named "Top 10" Most influential Hispanic Canadians for her significant contributions to cancer research.
Past media stories:
Dr. Paul Woods, ICCI co-director, was featured on CBC’s The National, highlighting OVC's participation in a North American wide trial exploring a novel treatment option for osteosarcoma patients.
CTV News reports on ICCI's continuing efforts in the fight against canine, and potentially human, bone cancer.
Globe and Mail article highlighting the comparative and translational research taking place at the OVC Mona Campbell Centre for Animal Cancer.
Global News story on the Animal Cancer Centre.
ICCI Team (Left to Right): Dr. Paul Woods (Co-Director), Dr. Kaya Skowronski (Tumour Bank Coordinator); Dr. Vicky Sabine (Clinical Research Coordinator), Dr. Michelle Oblak (Co-Assistant Director), Dr. Geoff Wood (Co-Assistant Director) and Dr. Brenda Coomber (Co-Director).